Bernard Maillere
8Patents
3h-index
26Co-inventors
53Inventor score
Filing activity: Mar 28, 2002 → Sep 12, 2017
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7488791B2 | Mixture of peptides derived from E6 and/or E7 papillomavirus proteins and uses thereof | Emerging Cross-Sectional Technologies | 9 | Expired |
| US6649166B1 | Peptides and proteins for desensitizing subjects allergic to bee venom and compositions containing same | Chemistry; Metallurgy | 6 | Expired |
| US9687539B2 | CD4+ T survivin epitopes and uses thereof | Human Necessities | 3 | Active |
| US9841429B2 | Method for real-time measurement of the individual secretions of a cell | Physics | 0 | Active |
| US10550166B2 | Immunogenic peptides of the cyclin B1 tumor antigen | Human Necessities | 0 | Active |
| US8715680B2 | HLA peptide therapy | Human Necessities | 0 | Active |
| US7718575B2 | Method of selecting HLA-DP4 ligands and the applications thereof | Physics | 0 | Expired |
| US9758552B2 | HB-EGF inhibitor derived from the R domain of diphtheria toxin for the treatment of diseases associated with the activation of the HB-EGF/EGFR pathway | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.